Evidence map›Paper›PMID 28199205›Full record

ReviewFrontiers in bioscience (Landmark edition)2017

The mucolipin-1 (TRPML1) ion channel, transmembrane-163 (TMEM163) protein, and lysosomal zinc handling.

Math P Cuajungco, Kirill Kiselyov

Abstract readReview
In one paragraph

Review in Frontiers in bioscience (Landmark edition), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Lysosome as a Chemical Reactor.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Lysosomal degradation products induceProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Transmembrane 163 (TMEM163) protein effluxes zinc.Archives of biochemistry and biophysics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Math P CuajungcoDepartment of Biological Science, and Center for Applied Biotechnology Studies, California State University Fullerton, Fullerton, CA, 92831, USA.
Kirill KiselyovDept. of Biological Sciences, University of Pittsburgh, 519 Langley Hall, 4249 Fifth Avenue, Pittsburgh, PA 15260, USA, kiselyov@pitt.edu.
University of Pittsburgh · US

Funding

MARC PROGRAM FOR CALIFORNIA STATE UNIVERSITY, FULLERTONT34GM008612 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI COHEN, AMYBETH · 1996 to 2021
$7.4M
Big Data Discovery and Diversity through Research Education Advancement and Partnerships (BD3-REAP)R25MD010397 · NIMHD · CALIFORNIA STATE UNIVERSITY FULLERTON · PI MCELIGOT, ARCHANA J · 2015 to 2019
$1.2M
DISSECTING THE ROLE OF TMEM163 PROTEIN IN CELLSR15NS101594 · NINDS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI CUAJUNGCO, MATH P · 2017 to 2020
$777k
Analysis of the Transcriptional Regulation and Expression of TRPML2R15NS070774 · NINDS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI CUAJUNGCO, MATH P · 2011 to 2011
$339k
NIGMS NIH HHS T34 GM008612NIMHD NIH HHS R25 MD010397NINDS NIH HHS R15 NS070774NINDS NIH HHS R15 NS101594
6 · The paper itself

Abstract

Lysosomes are emerging as important players in cellular zinc ion (Zn

Indexed as

Amino Acid SequenceAnimalsHumansIon TransportLysosomesMembrane ProteinsNeuronsTransient Receptor Potential ChannelsZincMCOLN1 protein, humanMembrane ProteinsTMEM163 protein, humanTransient Receptor Potential ChannelsZinc

Identifiers

PMID28199205
PMCPMC5517152
OpenAlexW2589044631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.